{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-25-003305","form_type":"8-K","ticker":"DRMA","cik":"0001853816","company_name":"Dermata Therapeutics, Inc.","filed_at":"2025-03-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.316228+00:00","generated_at":"2026-05-24T06:03:48.187247+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Dermata Therapeutics receives Nasdaq delisting notice for failing minimum stockholders' equity","bullets":["Nasdaq notified Dermata on March 25, 2025, of non-compliance with $2.5M minimum stockholders' equity rule.","Company reported stockholders' equity of $1.6M as of Dec 31, 2024, below required threshold.","Dermata has 45 days, until May 9, 2025, to submit a plan; possible extension to Sept 21, 2025.","Securities continue trading on Nasdaq while company evaluates options to regain compliance.","If plan rejected or compliance not regained, delisting proceedings may commence; hearing available."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-25-003305","json":"https://secwatch.observer/filing/0001654954-25-003305.json","markdown":"https://secwatch.observer/filing/0001654954-25-003305.md","text":"https://secwatch.observer/filing/0001654954-25-003305.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1853816/000165495425003305/0001654954-25-003305-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1853816/000165495425003305/drma_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T06:03:48.187247+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}